PMC7158927_01
Stage 3 neurotrophic keratitis with hypopyon and hyphema
TJO-10-54-g001.jpg
PMC7158927_01_TJO-10-54-g001.jpg
F1
She was also found to have a large central epithelial defect (5 mm x 7 mm) with central stromal infiltrates, and the anterior chamber was filled with hypopyon and hyphema which occluded the iris and view of the fundus [Figure 1].
Improvement of keratitis, epithelial defect, and resolving the anterior chamber reaction 1 month Post-tarsorrhaphy. Iris atrophy is not clearly seen in the picture
TJO-10-54-g002.jpg
PMC7158927_01_TJO-10-54-g002.jpg
F2
Given a persistent epithelial defect, a temporary tarsorrhaphy was carried out at 2 weeks into treatment after which there was a notable improvement of keratitis, healing of epithelial defect with a resolution of hypopyon, and hyphema with patchy iris atrophy [Figure 2] by the 2nd month of presentation.
Cornea scarring with vascularization and intrastromal hemorrhage
TJO-10-54-g003.jpg
PMC7158927_01_TJO-10-54-g003.jpg
F3
However, her vision remained poor at light perception and then clinically progressed to cornea scarring with vascularization and intrastromal hemorrhage by the 3rd month of presentation [Figure 3].
PMC7158927_02
A streak of hypopyon above a hyphema level in the anterior chamber
TJO-10-54-g004.jpg
PMC7158927_02_TJO-10-54-g004.jpg
F4
Anterior chamber showed the presence of a streak of hypopyon with a hyphema level (3.4 mm) below it [Figure 4].
Persistent cornea edema with epithelial defect, iris atrophy and ectropion uvea
TJO-10-54-g005.jpg
PMC7158927_02_TJO-10-54-g005.jpg
F5
Hyphema resolved after retreatment with topical dexamethasone 0.1% for 2 weeks; however, cornea edema and epithelial defect persisted [Figure 5] which necessitated surgical intervention such as tarsorrhaphy.